HLA I shields tumor lymphocytes from NK cell-mediated elimination in the skin

被引:0
|
作者
Chang, Yun-Tsan [1 ]
Kimeswenger, Susanne [2 ]
Tsai, Yi-Chien [1 ]
Prompsy, Pacome [1 ]
Pavlova, Olesya [1 ]
Pascolo, Steve [3 ]
Hoetzenecker, Wolfram [2 ]
Guenova, Emmanuella [1 ]
机构
[1] Lausanne Univ Hosp CHUV, Dermatol, Lausanne, Switzerland
[2] Johannes Kepler Univ Linz, Dermatol & Venerol, Linz, Austria
[3] Univ Zurich Hosp, Dermatol, Zurich, Switzerland
关键词
D O I
10.1016/j.ejca.2023.112992
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O-104
引用
收藏
页码:S2 / S2
页数:1
相关论文
共 50 条
  • [21] Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition
    Hallett, William H. D.
    Ames, Erik
    Motarjemi, Milad
    Barao, Isabel
    Shanker, Anil
    Tamang, David L.
    Sayers, Thomas J.
    Hudig, Dorothy
    Murphy, William J.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (01): : 163 - 170
  • [22] The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
    Garrido, Federico
    Perea, Francisco
    Bernal, Monica
    Sanchez-Palencia, Abel
    Aptsiauri, Natalia
    Ruiz-Cabello, Francisco
    VACCINES, 2017, 5 (01):
  • [23] TARGET ANTIGENS OF CELL-MEDIATED LYMPHOLYSIS DISCRIMINATION OF HLA SUBTYPES BY CYTOTOXIC LYMPHOCYTES
    ROBINSON, MA
    NOREEN, HJ
    AMOS, DB
    YUNIS, EJ
    JOURNAL OF IMMUNOLOGY, 1978, 121 (04): : 1486 - 1490
  • [24] KIR-HLA footprints and NK cell-mediated recognition of HIV-1
    CF Thobakgale
    J Carlson
    J Wright
    N van Teijlingen
    M Jaggernath
    P Goulder
    BD Walker
    M Carrington
    D Heckerman
    M Altfeld
    T Ndung'u
    Retrovirology, 9
  • [25] KIR-HLA footprints and NK cell-mediated recognition of HIV-1
    Thobakgale, C. F.
    Carlson, J.
    Wright, J.
    van Teijlingen, N.
    Jaggernath, M.
    Goulder, P.
    Walker, B. D.
    Carrington, M.
    Heckerman, D.
    Altfeld, M.
    Ndung'u, T.
    RETROVIROLOGY, 2012, 9
  • [26] Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity
    Karimi, Khalil
    Karimi, Yalda
    Chan, Jeffrey
    Boudreau, Jeanette E.
    Basset, Jennifer
    Chew, Marianne V.
    Reid, Sarah
    Bramson, Jonathan L.
    Wan, Yonghong
    Ashkar, Ali A.
    INNATE IMMUNITY, 2015, 21 (06) : 626 - 634
  • [27] Mechanisms of tumor cell resistance against NK cell-mediated cytolytic cell death.
    Lehmann, C
    Uharek, L
    Zeiss, M
    Glass, B
    Schmitz, N
    BLOOD, 1998, 92 (10) : 60B - 60B
  • [28] Functional visualization of NK cell-mediated killing of metastatic single tumor cells
    Ichise, Hiroshi
    Tsukamoto, Shoko
    Hirashima, Tsuyoshi
    Konishi, Yoshinobu
    Oki, Choji
    Tsukiji, Shinya
    Iwano, Satoshi
    Miyawaki, Atsushi
    Sumiyama, Kenta
    Terai, Kenta
    Matsuda, Michiyuki
    Rothlin, Carla, V
    ELIFE, 2022, 11
  • [29] NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
    Ruscetti, Marcus
    Leibold, Josef
    Bott, Matthew J.
    Fennell, Myles
    Kulick, Amanda
    Salgado, Nelson R.
    Chen, Chi-Chao
    Ho, Yu-jui
    Sanchez-Rivera, Francisco J.
    Fencht, Judith
    Baslan, Timour
    Tian, Sha
    Chen, Hsuan-An
    Romesser, Paul B.
    Poirier, John T.
    Rudin, Charles M.
    de Stanchina, Elisa
    Manchado, Eusebio
    Sherr, Charles J.
    Lowe, Scott W.
    SCIENCE, 2018, 362 (6421) : 1416 - +
  • [30] Enhancing NK cell-mediated tumor rejection by activation of the aryl hydrocarbon receptor
    Sunwoo, John
    Shin, June
    Zhang, Luhua
    Murillo, Oihana
    Kim, Junmo
    JOURNAL OF IMMUNOLOGY, 2011, 186